1. Research Framework
1.1. Research Objective
1.2. Product Type Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary and Secondary Sources
2.2. Quantitative Research
2.2.1. Primary and Secondary Sources
2.3. Breakdown of Primary Research Respondents
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Industry Participants
2.5. Key Questionnaire asked during Primary Interviews
2.6. Key Primary Responses
2.7. Market Size Estimation
2.8. Assumption for the Study
2.9. Market Breakdown & Data Triangulation
3. Executive Summary
4. India Generic Drugs Market Industry Insights
4.1. Value Chain
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.2.4. Challenges
4.3. Recent Developments / Technical Landscape
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.6. PESTEL Analysis
5. India Generic Drugs Market Overview, 2018-2028
5.1. Market Size & Forecast
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product Type
5.2.1.1. Simple Generics
5.2.1.2. Super Generics
5.2.1.3. Biosimilars
5.2.2. By Route of Administration
5.2.2.1. Oral
5.2.2.2. Topical
5.2.2.3. Injectable
5.2.2.4. Others
5.2.3. By Application
5.2.3.1. Cardiovascular Products
5.2.3.2. Anti-infective Drugs
5.2.3.3. Anti-arthritis Drugs
5.2.3.4. Central Nervous System Drugs
5.2.3.5. Anti-Cancer Drugs
5.2.3.6. Respiratory Products
5.2.3.7. Others
5.2.4. By Distribution Channel
5.2.4.1. Hospitals/Clinics
5.2.4.2. Retail Pharmacies
5.2.4.3. Other
6. Competitive Landscape
6.1.1. List of Key Producers and Their Offerings
6.1.2. Market Share / Ranking Analysis (2021)
6.1.3. Competitive Benchmarking, By Operating Parameters
7. COVID-19 Impact
8. Company Profiles (Company Overview, Financial Matrix, Key Product Type landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
8.1. Teva Pharmaceutical Industries
8.2. Wockhardt Pharmaceutical
8.3. Sandoz, A Novartis division
8.4. Fresenius Kabi
8.5. Aurobindo Pharma
8.6. Sun Pharma
8.7. Dr. Reddy
8.8. Lupin
8.9. Cipla
8.10. Viatris
8.11. Other Prominent Players
9. Key Strategic Recommendations
* Financial information of non-listed Companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.